BioInvenu Corporation provide the proprietary cell-based assay products and services to drug discovery researchers. BioInvenu is dedicated to develop assay products and services by utilizing a novel cell-based protein-protein interaction assay technology, LinkLight⢠technology. The LinkLight⢠technology was originally invented in Sanofi-Aventis. The technology utilizes protein-protein interactions as the functional signal readout. The technology has the potential for applying a broad range of drug targets that are difficult to tackle by existing methods. In additional for finding molecules that modulate protein-protein interaction signal cascades, the technology can be applied to protein-protein interaction drug targets by identifying molecules directly blocking protein-protein interactio
